Why do prostate cancers become resistant to treatment?

Presenter: Dr. Paul Toren
Original Date: February 27, 2018

Description:
Prostate cancer which has spread outside of the prostate gland is treated with systemic therapy. However, these treatments are not curative. Understanding the biological reasons for why these treatments do not work or become ineffective is important to identify better ways to treat patients. This presentation will give an overview of current understanding of why prostate cancers develop resistance to current therapies.
 
Download or order our B brochure.
 
 
 

Paul TorenPaul Toren's Biography:

Dr. Paul Toren completed his medical school at Queen's University in Kingston, Ontario and his urology residency and a clinical uro-oncology fellowship at the University of Toronto. Subsequently, he completed a two-year research fellowship at the Vancouver Prostate Centre under the mentorship of Dr. Martin Gleave. Concurrently, he enrolled in and recently completed a doctorate in experimental medicine in the laboratory of Dr. Amina Zoubeidi. Since 2015, he works as a clinician-scientist in the Department of Surgery at Laval University, where his laboratory focuses on translational prostate cancer research.

About Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

   

Donate Now!






Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive